JP Morgan Private Wealth Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.75M | Buy |
|
|||||
|
2023
Q2 | $3.51M | Sell |
|
|||||
|
2023
Q1 | $4.84M | Sell |
|
|||||
|
2022
Q4 | $4.93M | Buy |
|
|||||
|
2022
Q3 | $2.91M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $5.73M | Buy |
|
|||||
|
2021
Q4 | $5.32M | Buy |
|
|||||
|
2021
Q3 | $4.49M | Buy |
|
|||||
|
2021
Q2 | $4.27M | Buy |
|
|||||
|
2021
Q1 | $3.5M | Buy |
|
|||||
|
2020
Q4 | $3.42M | Sell |
|
|||||
|
2020
Q3 | $4.18M | Sell |
|
|||||
|
2020
Q2 | $4.54M | Sell |
|
|||||
|
2020
Q1 | $4.38M | Buy |
|
|||||
|
2019
Q4 | $4.76M | Buy |
|
|||||
|
2019
Q3 | $4.29M | Sell |
|
|||||
|
2019
Q2 | $4.04M | Sell |
|
|||||
|
2019
Q1 | $4.35M | Buy |
|
|||||
|
2018
Q4 | $3.95M | Sell |
|
|||||
|
2018
Q3 | $4.31M | Sell |
|
|||||
|
2018
Q2 | $4.65M | Buy |
|
|||||
|
2018
Q1 | $4.2M | Buy |
|
|||||
|
2017
Q4 | $2.67M | Sell |
|
|||||
|
2017
Q3 | $4.51M | Buy |
|
|||||
|
2017
Q2 | $4.44M | Sell |
|
|||||
|
2017
Q1 | $4.44M | Buy |
|
|||||
|
2016
Q4 | $2.62M | Sell |
|
|||||
|
2016
Q3 | $3.32M | Buy |
|
|||||
|
2016
Q2 | $2.96M | Buy |
|
|||||
|
2016
Q1 | $1.59M | Buy |
|
|||||
|
2015
Q4 | $1.21M | Buy |
|
|||||
|
2015
Q3 | $1.13M | Sell |
|
|||||
|
2015
Q2 | $1.51M | Buy |
|
|||||
|
2015
Q1 | $1.47M | Buy |
|
|||||
|
2014
Q4 | $1.26M | Buy |
|
|||||
|
2014
Q3 | $1.32M | Buy |
|
|||||
|
2014
Q2 | $1.12M | Buy |
|
|||||
|
2014
Q1 | $1.1M | Buy |
|
|||||
|
2013
Q4 | $868K | Buy |
|
|||||
|
2013
Q3 | $565K | Sell |
|
|||||
|
2013
Q2 | $703K | Buy |
|